ImpacTV
ImpacTV, hosted by Impact Venture Capital’s Jack Crawford, explores emerging tech trends, corporate venture insights, and startup innovation in fintech, data analytics, cybersecurity, and civic tech shaping tomorrow’s digital economy.
Allison Rhines on JLabs' innovation, AI in drug discovery, and healthcare tech trends | E30
Allison Rhines joins Jack Crawford to discuss her career in infectious disease modeling and the strategic focus of JLabs in collaboration with Johnson & Johnson. They delve into the role of digital health, capital efficiency, and AI in drug discovery. Allison describes JLabs' global reach, its history, and support for early-stage startups. The episode highlights the mentorship provided by J&J, the scouting and selection process, and the qualities JLabs values in potential companies. Emerging tech trends in healthcare, particularly in early cancer detection and precision oncology, are explored. The episode concludes with insights into personal and professional development in the industry.
Key Points
- JLABS focuses on overcoming non-scientific barriers for early-stage life sciences companies by providing connectivity to investors, mentorship, and access to a network of trusted service providers.
- JLABS companies benefit from a dedicated J&J mentor, known as a J PAL, who offers guidance and serves as a conduit to broader J&J resources, facilitating potential partnerships and investments.
- JLABS maintains a flexible approach to innovation, allowing companies working on transformative science that is either strategically aligned or adjacent to J&J's core areas of interest to join and potentially influence future strategic directions.
Chapters
| 0:00 | |
| 4:00 | |
| 8:33 | |
| 15:36 | |
| 22:20 | |
| 26:28 | |
| 28:04 | |
| 31:16 | |
| 32:29 | |
| 33:42 |
Transcript
Loading transcript...
- / -